We have collected information about Inhalation Delivery Of Therapeutic Peptides And Proteins for you. Follow the links to find out details on Inhalation Delivery Of Therapeutic Peptides And Proteins.
https://www.amazon.com/Inhalation-Delivery-Therapeutic-Peptides-Proteins/dp/0824797809
the systemic delivery of peptide and protein drugs using fine-particle technology gene therapy employing gene delivery through the airways new developments in pulmonary delivery technologies emphasizing inhaled peptide and protein drugsAuthor: Akwete Adjei
https://www.liebertpub.com/doi/abs/10.1089/jam.1999.12.45
Jan 30, 2009 · Quercetin solid lipid microparticles: A flavonoid for inhalation lung delivery European Journal of Pharmaceutical Sciences, Vol. 49, No. 2 Initial Observations of Cell-Mediated Drug Delivery to the Deep LungAuthor: John S. Patton
https://www.bookdepository.com/Inhalation-Delivery-Therapeutic-Peptides-Proteins-Akwete-Lex-Adjei/9780824797805
Inhalation Delivery of Therapeutic Peptides and Proteins by Akwete Lex Adjei, 9780824797805, available at Book Depository with free delivery worldwide.
https://www.sciencedirect.com/science/article/pii/0168365994900817
Pulmonary delivery of therapeutic peptides and proteins. Abstract. There have been many attempts to improve systemic delivery of peptide and protein drugs by routes of administration other than by injection. Studies in this area of drug delivery have included nasal, rectal, buccal and the transdermal route of administration.Author: A. Adjei, P. Gupta
https://www.worldcat.org/title/inhalation-delivery-of-therapeutic-peptides-and-proteins/oclc/37030499
Examining macromolecular drug delivery as an efficient, patient-friendly, and cost-effective method of treatment, Inhalation Delivery of Therapeutic Peptides and Proteins discusses airway physiology and biomechanics...the pharmaceutical concerns associated with the respiratory tract as a viable port of drug entry to the body...key peptide drugs under development and in use...the systemic delivery of peptide …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839019/
Apr 20, 2016 · Chronic inhalation therapy using these peptides could produce local immunogenicity and irritation, but given that SPLUNC1-derived peptides are naturally occurring in normal but not CF lungs, immunogenicity would seem unlikely . A limitation of this type of therapeutic is that it would only ameliorate CF lung disease and would not treat other CF-affected organs.Author: Robert C. Fellner, Shawn T. Terryah, Robert Tarran
Searching for Inhalation Delivery Of Therapeutic Peptides And Proteins?
You can just click the links above. The data is collected for you.
